Correlation between SARS-CoV-2 and ebola
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/23772 |
Resumo: | Introduction: The World Health Organization in 2020 declared the SARS-CoV-2 pandemic, which has high transmissibility causing a fatal acute respiratory syndrome. Furthermore, a rare and deadly disease, in addition to the above mentioned, proven by a virus is Ebola in primates (including man), which constitutes the most deadly and disseminated disease in global outbreaks. Objective: to establish a comparison between coronavirus and Ebola with a focus on mortality and lethality. Methodology: an integrative literature review using online databases such as: BVS, SCIELO, PUBMED, MEDLINE, WHO, IDRC, MS, CDC. Results and Discussions: In 2020, the 10th Ebola outbreak occurred and the 2nd largest since its discovery in 1976, 3,470 cases were reported. Currently, in 2021, according to Epidemiological Week (SE) 43, on October 30, 246,407,251 cases of COVID-19 have been confirmed in the world. Comparing the coronavirus, which has a fatality rate of 6.1% of infected people, with the threat of the Ebola virus, covering 90%, it is considered more aggravating, as it quickly causes the deaths of the sick. Conclusion: Thus, COVID-19 and Ebola are viruses that threaten global public health, due to their high rates of morbidity and mortality. However, it is necessary to follow the protocols and recommendations of the World Health Organization in the control and prevention of diseases. |
id |
UNIFEI_239d2509be634d84a6cb0b19b700defc |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/23772 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Correlation between SARS-CoV-2 and ebolaCorrelación entre SARS-CoV-2 y ebolaCorrelação entre SARS-CoV-2 e o ebolaLetalidadeCOVID-19SARS-CoV-2Ebolavirus.LetalidadCOVID-19SARS-CoV-2Ebolavirus.LethalityCOVID-19SARS-CoV-2Ebolavirus.Introduction: The World Health Organization in 2020 declared the SARS-CoV-2 pandemic, which has high transmissibility causing a fatal acute respiratory syndrome. Furthermore, a rare and deadly disease, in addition to the above mentioned, proven by a virus is Ebola in primates (including man), which constitutes the most deadly and disseminated disease in global outbreaks. Objective: to establish a comparison between coronavirus and Ebola with a focus on mortality and lethality. Methodology: an integrative literature review using online databases such as: BVS, SCIELO, PUBMED, MEDLINE, WHO, IDRC, MS, CDC. Results and Discussions: In 2020, the 10th Ebola outbreak occurred and the 2nd largest since its discovery in 1976, 3,470 cases were reported. Currently, in 2021, according to Epidemiological Week (SE) 43, on October 30, 246,407,251 cases of COVID-19 have been confirmed in the world. Comparing the coronavirus, which has a fatality rate of 6.1% of infected people, with the threat of the Ebola virus, covering 90%, it is considered more aggravating, as it quickly causes the deaths of the sick. Conclusion: Thus, COVID-19 and Ebola are viruses that threaten global public health, due to their high rates of morbidity and mortality. However, it is necessary to follow the protocols and recommendations of the World Health Organization in the control and prevention of diseases.Introducción: La Organización Mundial de la Salud en 2020 declaró la pandemia del SARS-CoV-2, que tiene una alta transmisibilidad y causa un síndrome respiratorio agudo fatal. Además, una enfermedad rara y mortal, además de las mencionadas anteriormente, probada por un virus es el Ébola en primates (incluido el hombre), que constituye la enfermedad más mortal y diseminada en los brotes mundiales. Objetivo: establecer una comparación entre coronavirus y ébola con enfoque en mortalidad y letalidad. Metodología: revisión integradora de la literatura utilizando bases de datos en línea como: BVS, SCIELO, PUBMED, MEDLINE, OMS, IDRC, MS, CDC. Resultados y discusiones: En 2020, ocurrió el décimo brote de ébola y el segundo más grande desde su descubrimiento en 1976, se reportaron 3.470 casos. Actualmente, en 2021, según la Semana Epidemiológica (SE) 43, el 30 de octubre se han confirmado 246.407.251 casos de COVID-19 en el mundo. Comparando el coronavirus, que tiene una tasa de letalidad del 6,1% de las personas infectadas, con la amenaza del virus del Ébola, que cubre el 90%, se considera más agravante, ya que provoca rápidamente la muerte de los enfermos. Conclusión: Así, el COVID-19 y el Ébola son virus que amenazan la salud pública mundial, debido a sus altas tasas de morbilidad y mortalidad. Sin embargo, es necesario seguir los protocolos y recomendaciones de la Organización Mundial de la Salud en el control y prevención de enfermedades.Introdução: A Organização Mundial de Saúde em 2020 declarou a pandemia do SARS-CoV-2, que apresenta alta transmissibilidade causando uma síndrome respiratória aguda fatal. Outrossim, uma doença rara e mortal, além do citado a cima, provada por um vírus é o do Ebola em primatas (incluído o homem), constituem como mais mortífero e disseminado nos surtos globais. Objetivo: estabelecer a comparação entre o coronavirus e o ebola com foco na mortalidade e letalidade. Metodologia: uma revisão integrativa da literatura, utilizando bancos de dados online como: BVS, SCIELO, PUBMED, MEDLINE, WHO, IDRC, MS, CDC. Resultado e Discussões: Em 2020, ocorreu o 10° surto de Ebola e a 2° maior desde sua descoberta em 1976, notificou-se 3.470 casos. Atualmente em 2021, conforme a Semana Epidemiológica (SE) 43, em 30 de outubro, confirmou-se 246.407.251 casos de COVID-19 no mundo. Comparando o coronavírus, que possui sua letalidade de 6,1% das pessoas eivadas, com a ameaça do Ebola vírus, abrangendo 90%, considera-se mais agravante, por ocasionar rapidamente as mortes dos enfermos. Conclusão: Dessa forma, a COVID-19 e o Ebola são vírus de ameaças a saúde pública global, devido as suas elevadas taxas de morbidade e mortalidade. Contudo, carece seguir os protocolos e as recomendações da Organização Mundial da Saúde no controle e prevenção das enfermidades.Research, Society and Development2021-12-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2377210.33448/rsd-v10i16.23772Research, Society and Development; Vol. 10 No. 16; e294101623772Research, Society and Development; Vol. 10 Núm. 16; e294101623772Research, Society and Development; v. 10 n. 16; e2941016237722525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/23772/20934Copyright (c) 2021 Nágila Iane Pacheco; Luiza Aragão Paiva Pires Ferreira Mendes; Gabriel de Sousa Carneiro; Mariana Pacheco de Sousa; Jucilene da Silva Sousa ; Ian Carlos Cavalcante Vasconcelos ; Bruna Ellen Ribeiro de Oliveira; Bruna da Silva Azevedo; Isabelle Vasconcelos Rodrigues; Adryana Ryta Ribeiro Sousa Lira; Jorge Davi de Sousa e Silva; Fernando Henrique Lima Sa Machado; Jordianne Thamires Rodrigues Bezerra; Veronildes de Sousa e Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPacheco, Nágila IaneMendes, Luiza Aragão Paiva Pires Ferreira Carneiro, Gabriel de SousaSousa, Mariana Pacheco de Sousa , Jucilene da Silva Vasconcelos , Ian Carlos Cavalcante Oliveira, Bruna Ellen Ribeiro de Azevedo, Bruna da Silva Rodrigues, Isabelle Vasconcelos Lira, Adryana Ryta Ribeiro Sousa Silva, Jorge Davi de Sousa e Machado, Fernando Henrique Lima Sa Bezerra, Jordianne Thamires Rodrigues Silva, Veronildes de Sousa e2021-12-20T11:03:07Zoai:ojs.pkp.sfu.ca:article/23772Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:42:32.124789Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Correlation between SARS-CoV-2 and ebola Correlación entre SARS-CoV-2 y ebola Correlação entre SARS-CoV-2 e o ebola |
title |
Correlation between SARS-CoV-2 and ebola |
spellingShingle |
Correlation between SARS-CoV-2 and ebola Pacheco, Nágila Iane Letalidade COVID-19 SARS-CoV-2 Ebolavirus. Letalidad COVID-19 SARS-CoV-2 Ebolavirus. Lethality COVID-19 SARS-CoV-2 Ebolavirus. |
title_short |
Correlation between SARS-CoV-2 and ebola |
title_full |
Correlation between SARS-CoV-2 and ebola |
title_fullStr |
Correlation between SARS-CoV-2 and ebola |
title_full_unstemmed |
Correlation between SARS-CoV-2 and ebola |
title_sort |
Correlation between SARS-CoV-2 and ebola |
author |
Pacheco, Nágila Iane |
author_facet |
Pacheco, Nágila Iane Mendes, Luiza Aragão Paiva Pires Ferreira Carneiro, Gabriel de Sousa Sousa, Mariana Pacheco de Sousa , Jucilene da Silva Vasconcelos , Ian Carlos Cavalcante Oliveira, Bruna Ellen Ribeiro de Azevedo, Bruna da Silva Rodrigues, Isabelle Vasconcelos Lira, Adryana Ryta Ribeiro Sousa Silva, Jorge Davi de Sousa e Machado, Fernando Henrique Lima Sa Bezerra, Jordianne Thamires Rodrigues Silva, Veronildes de Sousa e |
author_role |
author |
author2 |
Mendes, Luiza Aragão Paiva Pires Ferreira Carneiro, Gabriel de Sousa Sousa, Mariana Pacheco de Sousa , Jucilene da Silva Vasconcelos , Ian Carlos Cavalcante Oliveira, Bruna Ellen Ribeiro de Azevedo, Bruna da Silva Rodrigues, Isabelle Vasconcelos Lira, Adryana Ryta Ribeiro Sousa Silva, Jorge Davi de Sousa e Machado, Fernando Henrique Lima Sa Bezerra, Jordianne Thamires Rodrigues Silva, Veronildes de Sousa e |
author2_role |
author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Pacheco, Nágila Iane Mendes, Luiza Aragão Paiva Pires Ferreira Carneiro, Gabriel de Sousa Sousa, Mariana Pacheco de Sousa , Jucilene da Silva Vasconcelos , Ian Carlos Cavalcante Oliveira, Bruna Ellen Ribeiro de Azevedo, Bruna da Silva Rodrigues, Isabelle Vasconcelos Lira, Adryana Ryta Ribeiro Sousa Silva, Jorge Davi de Sousa e Machado, Fernando Henrique Lima Sa Bezerra, Jordianne Thamires Rodrigues Silva, Veronildes de Sousa e |
dc.subject.por.fl_str_mv |
Letalidade COVID-19 SARS-CoV-2 Ebolavirus. Letalidad COVID-19 SARS-CoV-2 Ebolavirus. Lethality COVID-19 SARS-CoV-2 Ebolavirus. |
topic |
Letalidade COVID-19 SARS-CoV-2 Ebolavirus. Letalidad COVID-19 SARS-CoV-2 Ebolavirus. Lethality COVID-19 SARS-CoV-2 Ebolavirus. |
description |
Introduction: The World Health Organization in 2020 declared the SARS-CoV-2 pandemic, which has high transmissibility causing a fatal acute respiratory syndrome. Furthermore, a rare and deadly disease, in addition to the above mentioned, proven by a virus is Ebola in primates (including man), which constitutes the most deadly and disseminated disease in global outbreaks. Objective: to establish a comparison between coronavirus and Ebola with a focus on mortality and lethality. Methodology: an integrative literature review using online databases such as: BVS, SCIELO, PUBMED, MEDLINE, WHO, IDRC, MS, CDC. Results and Discussions: In 2020, the 10th Ebola outbreak occurred and the 2nd largest since its discovery in 1976, 3,470 cases were reported. Currently, in 2021, according to Epidemiological Week (SE) 43, on October 30, 246,407,251 cases of COVID-19 have been confirmed in the world. Comparing the coronavirus, which has a fatality rate of 6.1% of infected people, with the threat of the Ebola virus, covering 90%, it is considered more aggravating, as it quickly causes the deaths of the sick. Conclusion: Thus, COVID-19 and Ebola are viruses that threaten global public health, due to their high rates of morbidity and mortality. However, it is necessary to follow the protocols and recommendations of the World Health Organization in the control and prevention of diseases. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-12-12 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/23772 10.33448/rsd-v10i16.23772 |
url |
https://rsdjournal.org/index.php/rsd/article/view/23772 |
identifier_str_mv |
10.33448/rsd-v10i16.23772 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/23772/20934 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 16; e294101623772 Research, Society and Development; Vol. 10 Núm. 16; e294101623772 Research, Society and Development; v. 10 n. 16; e294101623772 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052809769648128 |